25 Apr 2017 | 3:39 PM
 

Marksans Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524404 | NSE Symbol: MARKSANS
52.10
1.00
(1.96 %)
25 Apr 2017 | 03:30 PM
Change company
  • Open (Rs)
    51.45
  • Prev. close (Rs.)
    51.10
  • High (Rs.)
    53.40
  • Low (Rs.)
    49.65
  • 52W H (Rs.)
    58.30
  • 52W L (Rs.)
    36.96
  • Volume (Rs.)
    1681366
  • MCap (Rs in Cr.)
    2,132.53
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
1.92
Operating Margin (%)
15.25
Gross Profit Margin (%)
12.10
Net Profit Margin (%)
8.78
Total Debt/Equity
0.20
Dividend payout Ratio (Net Profit)
22.87
Earning Retention Ratio
78.30

News

10 Apr 2017 - 14:27:00-Drug firm Marksans Pharma today said the US health regulator has issued four observations after comp...
06 Feb 2017 - 15:57:00-Marksans Pharma has reported of decline of 37 per cent in its consolidated net profit after taxes (P...
18 Oct 2016 - 14:59:00-Marksans Pharma Ltd an Indian pharma firm having global footprint on Tuesday said it has received ap...
26 Sep 2016 - 12:42:00-Shares of Marksans Pharma rallied over 12 per cent on the Bombay Stock Exchange after the drug maker...

Announcements

18-Apr-2017
Marksans Pharma - Shareholding for the Period Ended March 31 2017
13-Apr-2017
Marksans Pharma - Certificate Pursuant To Regulation 40 (9) Of SEBI (Listing Obligations And Disclosures Requirements) Regula
11-Apr-2017
Marksans Pharma - Compliance Certificate For The Period Ended 31St March 2017
10-Apr-2017
Marksans Pharma - Statement Of Investor Complaints For The Quarter Ended 31St March 2017
10-Apr-2017
Marksans Pharma - Updates

Religare Research

24 Apr 2017 | 07:39 PM
• Gold prices edged higher on Friday as investors remained cautious ahead of the first round of voti...
24 Apr 2017 | 06:00 PM
Tech Stars, comprises our 2 top stock picks filtered on the basis of momentum from our coverage univ...
24 Apr 2017 | 09:50 AM
Gold falls as stocks gain after French election result Oil dives, U.S. crude below $50 for first tim...
24 Apr 2017 | 09:45 AM
The Indian rupee ended lower for a second consecutive week, posting its biggest weekly fall since De...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
6,68,725 6.05 26.30 0.57
6,68,725 6.05 36.12 0.57
6,68,725 6.05 37.87 0.58
6,68,725 6.05 27.70 0.58

Shareholding Pattern

       
Promotors48.25%
Mutual Funds/UTI0.00%
FI/Banks5.02%
Insurance5.02%
FII10.52%
Government0.00%
Others7.29%

Peer Group

Company Intraday Graph
 Neuland Laboratories Ltd.
1,405.00(3.31)
3578
 Kovai Medical Center and Hospital Ltd.
1,219.95(1.06)
11816
 Merck Ltd.
1,086.35(-1.28)
3302
 Coral Laboratories Ltd.
931.00(0.13)
3462

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Marksans Pharma Ltd.4.7513.600.40
NIFTY(S&P CNX)198.60830.80597.65
BSE SENSEX497.802,543.621,740.12
BSE 500492.581,413.361,025.27

Corporate Details

Key Personal
Mark Saldanha
Chairman & Managing Director
Sandra Saldanha
Whole Time Director
Vinay Gopal Nayak
Whole Time Director
Key Address
Registered Office
11th Floor Grandeur Veera Desai Extension Road Oshiwara Andheri (West),Mumbai,Maharashtra

Tel:022-40012000, Fax:022-40012011

info@marksanspharma.com
http://www.marksanspharma.com
Registrar Office
Bigshare Services Pvt. Ltd.
Add. :E-2 & 3 Ansa Industrial Estate Saki-Vihar Road Sakinaka Andheri East

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Marksans Pharma Ltd. that will help you decide whether to buy, sell or hold Marksans Pharma Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Marksans Pharma Ltd.